文献速递临床试验与 GCP

院外心脏骤停复苏后血压目标与脑能量状态床旁监测随机临床试验的设计论文

Design paper of the "Blood pressure targets in post-resuscitation care and bedside monitoring of cerebral energy state: a randomized clinical trial".
PubMed 文献 · Trials · 2019-06-10

本研究为单中心、随机、双盲、优效性试验,计划纳入60例院外心脏骤停复苏后持续自主循环恢复的昏迷患者,按1:1随机分至低平均动脉压目标组(63 mmHg)或高平均动脉压目标组(77 mmHg),主要终点为48小时内两组平均乳酸/丙酮酸比值差异,并评估该比值与ICU全因死亡率及出院时神经功能不良生存的关联。

要点

  • 试验比较OHCA复苏后昏迷患者平均动脉压目标63 mmHg与77 mmHg对脑代谢的影响。
  • 主要终点为48小时内乳酸/丙酮酸比值组间差异。
  • 颈静脉球微透析作为床旁评估全脑能量状态的新诊断工具。

核心结论

  • 颈静脉球微透析可能提供可靠的全局脑代谢状态评估,可作为OHCA后ICU患者全新的、侵入性较小的诊断工具,并对早期预后和治疗有启示。

研究设计与样本

  • 单中心、随机、双盲、优效性试验,计划纳入60例院外心脏骤停后持续自主循环恢复的昏迷患者,按1:1随机分至低平均动脉压目标组(63 mmHg)或高平均动脉压目标组(77 mmHg)。

主要发现

  • 主要终点为48小时内两组平均乳酸/丙酮酸比值差异。
  • 次要终点为乳酸/丙酮酸比值与ICU全因死亡率的关联,以及乳酸/丙酮酸比值与出院时神经功能不良生存的关联。
  • 近期实验和临床研究提示,可能通过测量引流静脉血的乳酸/丙酮酸比值评估脑氧化代谢。

临床怎么用

  • 作者认为颈静脉球微透析可能提供可靠的全局脑代谢状态评估,可作为OHCA后ICU患者全新的、侵入性较小的诊断工具,并对早期预后和治疗有启示。

局限性

  • 目前尚无床旁评估全局脑能量状态的技术,血压目标一直基于有限的临床证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neurological injuries remain the leading cause of death in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA). Adequate blood pressure is of paramount importance to optimize cerebral perfusion and to minimize secondary brain injury. Markers measuring global cerebral ischemia caused by cardiac arrest and consecutive resuscitation and reflecting the metabolic variations after successful resuscitation are needed to assist a more individualized post-resuscitation care. Currently, no technique is available for bedside evaluation of global cerebral energy state, and until now blood pressure targets have been based on limited clinical evidence. Recent experimental and clinical studies indicate that it might be possible to evaluate cerebral oxidative metabolism from measuring the lactate-to-pyruvate (LP) ratio of the draining venous blood. In this study, jugular bulb microdialysis and immediate bedside biochemical analysis are introduced as new diagnostic tools to evaluate the effect of higher mean arterial blood pressure on global cerebral metabolism and the degree of cellular damage after OHCA. METHODS/DESIGN: This is a single-center, randomized, double-blinded, superiority trial. Sixty unconscious patients with sustained return of spontaneous circulation after OHCA will be randomly assigned in a one-to-one fashion to low (63 mm Hg) or high (77 mm Hg) mean arterial blood pressure target. The primary end-point will be a difference in mean LP ratio within 48 h between blood pressure groups. Secondary end-points are (1) association between LP ratio and all-cause intensive care unit (ICU) mortality and (2) association between LP ratio and survival to hospital discharge with poor neurological function. DISCUSSION: Markers measuring cerebral ischemia caused by cardiac arrest and consecutive resuscitation and reflecting the metabolic changes after successful resuscitation are urgently needed to enable a more personalized post-resuscitation care and prognostication. Jugular bulb microdialysis may provide a reliable global estimate of cerebral metabolic state and can be implemented as an entirely new and less invasive diagnostic tool for ICU patients after OHCA and has implications for early prognosis and treatment. TRIAL REGISTRATION: ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT03095742 ). Registered March 30, 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mölström S, Nielsen TH, Nordström CH, et al. Design paper of the "Blood pressure targets in post-resuscitation care and bedside monitoring of cerebral energy state: a randomized clinical trial". Trials. 2019. PMID: 31182135. doi:10.1186/s13063-019-3397-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。